April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop WHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Sprin
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop April 24 – 25, 2019 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 24-25, 2019 the Tenth Ann
April 16, 2019 C-Path, CDISC Develop Therapeutic Area Standard to Foster More Efficient and Meaningful Research for HIV TUCSON, Ariz. and AUSTIN, April 16, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce
April 9, 2019 C-Path Receives Qualification for the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) TUCSON, Ariz., April 9, 2019 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S.
April 5, 2019 Muscular Dystrophy Association 2019 Clinical and Scientific Conference Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Or
March 26, 2019 Critical Path Institute and Japan’s Pharmaceuticals and Medical Devices Agency Collaborate on First-of-its-Kind Biomarker Project Aim is to generate critical data to support safety decisions made in early-stage clinical trials TUCSON, Ariz., March 26, 2
March 21, 2019 C-Path Selects Global Regulatory Affairs Leader as New President and CEO TUCSON, Ariz., March 21, 2019 — After a worldwide search, the Critical Path Institute (C-Path) today announced it has appointed
March 19, 2019 The Importance of Drug Safety and Tolerability in the Development of New Immunosuppressive Therapy for Transplant Recipients
March 18, 2019 Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson’s Disease Romero K, Conrado D, Burton J, Nicholas T, Sinha V, Macha S, Ahamadi M, Cedarbaum J, Seibyl J, Marek K, Basseches P, Hill D...
March 18, 2019 C-Path President and CEO, Board Director Selected to Serve on Esteemed National Academies of Sciences, Engineering and Medicine Committee C-Path President and CEO Martha Brumfield, PhD, and C-Path Board Director Alastair J. Wood, MD, FRCP, have both been selected to t